AR and neoplasm: Our results show that IA-based enrichment of tumor-derived exosomes (Exosomics SoRTEVTM RNA Enrichment Kit) outperforms the total circulating exosomes isolation method in the detection of the AR-V7 variant in CRPC plasma samples.